These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15790166)

  • 1. Hormone replacement therapy and venous thromboembolism.
    Walker ID
    Thromb Res; 2005 Feb; 115 Suppl 1():88-92. PubMed ID: 15790166
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy and risk of venous thromboembolism--still unresolved questions.
    Sandset PM
    J Thromb Haemost; 2006 Jan; 4(1):68-9. PubMed ID: 16409452
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone replacement therapy and risk for venous thromboembolism: what's new and how do these findings influence clinical practice?
    Douketis J
    Curr Opin Hematol; 2005 Sep; 12(5):395-400. PubMed ID: 16093786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease.
    Lowe GD
    J Intern Med; 2004 Nov; 256(5):361-74. PubMed ID: 15485471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study].
    Canonico M; Scarabin PY
    Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
    Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
    Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
    Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
    Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy, thrombosis and thrombophilia.
    Keeling DM
    J Br Menopause Soc; 2005 Jun; 11(2):74-5. PubMed ID: 15970020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic influence of hormone-replacement therapy on venous thromboembolism.
    Sumino H; Ichikawa S; Kumakura H; Takayama Y; Kurabayashi M
    Lancet; 2003 Oct; 362(9391):1242. PubMed ID: 14568759
    [No Abstract]   [Full Text] [Related]  

  • 11. Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism.
    Ambrus JL
    Am J Med; 1999 Jul; 107(1):104. PubMed ID: 10403362
    [No Abstract]   [Full Text] [Related]  

  • 12. Postmenopausal hormone replacement and venous thromboembolism following hip and knee arthroplasty.
    Hurbanek JG; Jaffer AK; Morra N; Karafa M; Brotman DJ
    Thromb Haemost; 2004 Aug; 92(2):337-43. PubMed ID: 15269830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex hormones and thrombosis.
    Watson HG
    Semin Hematol; 2007 Apr; 44(2):98-105. PubMed ID: 17433902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive mesenteric and portal venous thrombosis secondary to hormone replacement therapy.
    Watt DG; Shapter O; Mittapalli D; Murray WG
    Scott Med J; 2013 Nov; 58(4):e8-10. PubMed ID: 24215058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.
    Rexrode KM; Manson JE
    Circulation; 2007 Feb; 115(7):820-2. PubMed ID: 17309929
    [No Abstract]   [Full Text] [Related]  

  • 16. HRT and venous thromboembolism: more evidence of a link.
    Chen BH
    CMAJ; 2001 Jan; 164(1):87. PubMed ID: 11202677
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormone replacement therapy and arterial thrombotic disease.
    Middeldorp S
    Thromb Res; 2005 Feb; 115 Suppl 1():68-71. PubMed ID: 15790160
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.
    Oger E; Scarabin PY
    Drugs Aging; 1999 Jan; 14(1):55-61. PubMed ID: 10069408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thromboembolism with use of antipsychotic drugs.
    Tapson VF
    Lancet; 2000 Oct; 356(9237):1206. PubMed ID: 11072931
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term hormonal treatment for transgender people.
    den Heijer M; Bakker A; Gooren L
    BMJ; 2017 Nov; 359():j5027. PubMed ID: 29192092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.